BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27116211)

  • 1. Cataract development in patients treated with proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.
    Mathis T; Rosier L; Meniai F; Baillif S; Maschi C; Herault J; Caujolle JP; Kodjikian L; Salleron J; Thariat J
    Am J Ophthalmol; 2019 May; 201():63-71. PubMed ID: 30721686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage proton beam therapy in local recurrent uveal melanoma.
    Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
    Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
    Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lens changes after proton beam irradiation for uveal melanoma.
    Gragoudas ES; Egan KM; Walsh SM; Regan S; Munzenrider JE; Taratuta V
    Am J Ophthalmol; 1995 Feb; 119(2):157-64. PubMed ID: 7832221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
    Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cataract Avoidance With Proton Therapy in Ocular Melanomas.
    Thariat J; Jacob S; Caujolle JP; Maschi C; Baillif S; Angellier G; Mathis T; Rosier L; Carnicer A; Hérault J; Salleron J
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5378-5386. PubMed ID: 29049739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.
    Meecham WJ; Char DH; Kroll S; Castro JR; Blakely EA
    Arch Ophthalmol; 1994 Feb; 112(2):197-203. PubMed ID: 8311772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
    Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
    Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabeculectomy in patients with uveal melanoma after proton beam therapy.
    Riechardt AI; Cordini D; Rehak M; Hager A; Seibel I; Böker A; Gundlach E; Heufelder J; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1379-85. PubMed ID: 26960442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
    Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
    Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
    Seibel I; Hager A; Riechardt AI; Davids AM; Böker A; Joussen AM
    Am J Ophthalmol; 2016 Aug; 168():31-39. PubMed ID: 27163234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
    Bellerive C; Aziz HA; Bena J; Wilkinson A; Suh JH; Plesec T; Singh AD
    Am J Ophthalmol; 2017 May; 177():9-16. PubMed ID: 28163118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.